Pv. Dicpinigaitis et al., COMPARISON OF THE ANTITUSSIVE EFFECTS OF CODEINE AND THE GABA-AGONISTBACLOFEN, Clinical drug investigation, 14(4), 1997, pp. 326-329
gamma-Aminobutyric acid (GABA) is an inhibitory transmitter of the cen
tral nervous system that also exists in peripheral tissues, including
the lung. The GABA-agonist baclofen has been shown, in animal studies,
to inhibit cough via a central mechanism. We have recently demonstrat
ed the antitussive activity of a 14-day course of low-dose oral baclof
en in normal subjects. In the present study, we evaluated a standard c
ough suppressant, codeine, and compared its antitussive effect with th
at of a single dose of baclofen. 10 healthy, adult volunteers; who had
previously participated in a study evaluating the antitussive effect
of a 14-day course of baclofen. underwent capsaicin cough challenge on
three occasions, 2 hours after the ingestion of codeine (30mg), baclo
fen (40mg) or placebo, which were dispensed in a randomised, double-bl
ind manner. During each study, the concentration of capsaicin inducing
5 or more coughs (C-5) was determined. Significant suppression of cou
gh was achieved by codeine (p = 0.021). Although a single dose of bacl
ofen demonstrated cough suppression in some individuals, its effect wa
s not significant for the study group as a whole (p = 0.066). The chan
ge in cough threshold from baseline (Delta log C-5) produced by single
doses of codeine and baclofen were not significantly different (p = 0
.434). In light of our previous study that demonstrated the significan
t antitussive effect of a 14-day course of low-dose baclofen. the inab
ility of a single, large dose of baclofen to suppress cough in the cur
rent study suggests the need for multiple administrations to achieve t
he optimal inhibitory effect of this agent.